Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV.

Approximately 80 percent of all human sera that react with antigens of HTLV-III, the etiologic agent of the acquired immune deficiency syndrome (AIDS), recognize protein bands at 66 and 51 kilodaltons. A mouse hybridoma was produced that was specific to these proteins. Repeated cloning of the hybridoma did not separate the two reactivities. The p66/p51 was purified from HTLV-III lysates by immunoaffinity chromatography and subjected to NH2-terminal Edman degradation. Single amino acid residues were obtained in 17 successive degradation cycles. The sequence determined was a perfect translation of the nucleotide sequence of a portion of the HTLV-III pol gene. The purified p66/51 had reverse transcriptase activity and the monoclonal immunoglobulin G specifically removed the enzyme activity from crude viral extract as well as purified enzyme.

[1]  D W Barry,et al.  3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[2]  T. Copeland,et al.  Characterization of gp41 as the transmembrane protein coded by the HTLV-III/LAV envelope gene. , 1985, Science.

[3]  S. Salahuddin,et al.  Isolation of infectious human T-cell leukemia/lymphotropic virus type III (HTLV-III) from patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex (ARC) and from healthy carriers: a study of risk groups and tissue sources. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[4]  G. Gerard,et al.  Amino- and carboxyl-terminal sequence of Moloney murine leukemia virus reverse transcriptase. , 1985, Virology.

[5]  J. Sodroski,et al.  Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III. , 1985, Science.

[6]  M. Gonda,et al.  Characterization of envelope and core structural gene products of HTLV-III with sera from AIDS patients. , 1985, Science.

[7]  Mark L. Pearson,et al.  Complete nucleotide sequence of the AIDS virus, HTLV-III , 1985, Nature.

[8]  S. Matsushita,et al.  Suramin protection of T cells in vitro against infectivity and cytopathic effect of HTLV-III. , 1984, Science.

[9]  R. Gallo,et al.  Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. , 1984, Science.

[10]  J Schüpbach,et al.  Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. , 1984, Science.

[11]  C. Reading,et al.  Theory and methods for immunization in culture and monoclonal antibody production. , 1982, Journal of immunological methods.

[12]  L. Hood,et al.  A gas-liquid solid phase peptide and protein sequenator. , 1981, The Journal of biological chemistry.

[13]  G. Gerard.  Mechanism of action of Moloney murine leukemia virus RNA-directed DNA polymerase associated RNase H (RNase H I). , 1981, Biochemistry.

[14]  T. Copeland,et al.  Amino Acid Sequence Analysis of Reverse Transcriptase Subunits from Avian Myeloblastosis Virus , 1980, Journal of virology.

[15]  T. Copeland,et al.  Separation of amino acid phenylthiohydantoins by high-performance liquid chromatography on phenylalkyl support. , 1980, Analytical biochemistry.

[16]  M. Golomb,et al.  Endonuclease activity of purified RNA-directed DNA polymerase from avian myeloblastosis virus. , 1979, The Journal of biological chemistry.